Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Medical - Devices

Healthcare
$16.80 +1.53%

+$0.24 today

Market cap
$1.17B
Beta
1.57
P/E (TTM)
-11.3
EPS (TTM)
-$1.38
52W Low $9.98High $29.65

Volume 2.30M

Average 2.43M

Returns on capital

Tandem Diabetes Care, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-131.9%

avg 106.5%

ROIC

-11.9%

avg -34.1%

ROA

-23.2%

avg -31.3%

Analysis

ROIC is currently the strongest return metric at -11.9% versus its period average of -34.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

John F. Sheridan

President, Chief Executive Officer & DirectorUSD 1.49M7117.95K0.03%

Leigh A. Vosseller

Executive Vice President, Chief Financial Officer & TreasurerUSD 764.04K53——

Elizabeth Anne Gasser

Executive Vice President and Chief Strategy & Product OfficerUSD 712.21K50508<0.01%

Shannon Hansen

Executive Vice President, Chief Legal, Privacy & Compliance Officer and SecretaryUSD 712.17K60——

Susan Morrison

Executive Vice President & Chief Administrative OfficerUSD 697.84K473.29K<0.01%

Jean-Claude E. Kyrillos

Executive Vice President & Chief Operating OfficerUSD 538.56K62——

Jordan Pinsker

Chief Medical Officer————

Tom Fox

Executive VP & Chief Human Resources Officer————

Rick A. Carpenter

Executive VP & CTO—63——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 15, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

3

$36,910.97

Net Transaction Value

−$36,910.97

Net selling

Most Active

Novara Mark David

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Oct 27, 26

TWOMEY CHRISTOPHER J

Direct

Sell$32.6K
Mar 17, 26

Novara Mark David

Direct

Sell$4.3K
Mar 5, 26

Novara Mark David

Direct

Sell$45.6

Summary

Insiders reported 0 buys worth $0.00 and 3 sells worth $36,910.97 over the last 12 months. That adds up to net selling of $36,910.97. Novara Mark David was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A13 analysts
RevenueN/AN/A+8.2%
+10.1% (5yr)9 analysts
Net IncomeN/AN/AN/A
N/A9 analysts
EBITN/AN/AN/A
N/A9 analysts

Analysis

Recent growth has been strongest in Revenue at +8.2% over three years. Forward estimates point to Revenue at +10.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Tandem Diabetes Care, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about TNDM's management, answered from reported figures.

Who manages TNDM?

Tandem Diabetes Care, Inc. (TNDM) lists 9 active executives. The top listed executive is Jordan Pinsker, Chief Medical Officer.

Are TNDM insiders buying or selling?

Recent insider activity shows net selling of $1.45M.